Enanta Pharmaceuticals Stock Price History
| ENTA Stock | USD 7.10 0.01 0.14% |
Below is the normalized historical share price chart for Enanta Pharmaceuticals extending back to March 21, 2013. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Enanta Pharmaceuticals stands at 7.10, as last reported on the 6th of August, with the highest price reaching 7.15 and the lowest price hitting 6.88 during the day.
If you're considering investing in Enanta Stock, it is important to understand the factors that can impact its price. Enanta Pharmaceuticals appears to be slightly risky, given 3 months investment horizon. Enanta Pharmaceuticals secures Sharpe Ratio (or Efficiency) of 0.14, which denotes the company had a 0.14 % return per unit of standard deviation over the last 3 months. By reviewing Enanta Pharmaceuticals' technical indicators, you can evaluate if the expected return of 0.56% is justified by implied risk. Please utilize Enanta Pharmaceuticals' Downside Deviation of 4.27, mean deviation of 3.16, and Semi Deviation of 4.02 to check if our risk estimates are consistent with your expectations. At present, Enanta Pharmaceuticals' Total Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Stock Based Compensation is expected to grow to about 32.4 M, whereas Common Stock Shares Outstanding is forecasted to decline to about 19.6 M. . At present, Enanta Pharmaceuticals' Price Book Value Ratio is projected to increase slightly based on the last few years of reporting. The current year's Price Earnings To Growth Ratio is expected to grow to 0.16, whereas Price To Sales Ratio is forecasted to decline to 3.54. Enanta Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 21st of March 2013 | 200 Day MA 7.123 | 50 Day MA 7.2038 | Beta 0.884 |
Sharpe Ratio = 0.1352
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ENTA | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.11 actual daily | 36 64% of assets are more volatile |
Expected Return
| 0.56 actual daily | 11 89% of assets have higher returns |
Risk-Adjusted Return
| 0.14 actual daily | 10 90% of assets perform better |
Based on monthly moving average Enanta Pharmaceuticals is performing at about 10% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Enanta Pharmaceuticals by adding it to a well-diversified portfolio.
Price Book 1.6249 | Enterprise Value Ebitda (0.29) | Price Sales 2.3544 | Shares Float 14.4 M | Wall Street Target Price 18.2 |
Enanta Pharmaceuticals Stock Price History Chart
There are several ways to analyze Enanta Stock price data. The simplest method is using a basic Enanta candlestick price chart, which shows Enanta Pharmaceuticals price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | July 29, 2025 | 8.1 |
| Lowest Price | May 14, 2025 | 5.18 |
Enanta Pharmaceuticals August 6, 2025 Stock Price Synopsis
Various analyses of Enanta Pharmaceuticals' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Enanta Stock. It can be used to describe the percentage change in the price of Enanta Pharmaceuticals from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Enanta Stock.| Enanta Pharmaceuticals Price Rate Of Daily Change | 1.00 | |
| Enanta Pharmaceuticals Price Action Indicator | 0.08 | |
| Enanta Pharmaceuticals Price Daily Balance Of Power | (0.04) |
Enanta Pharmaceuticals August 6, 2025 Stock Price Analysis
Enanta Stock Price History Data
The price series of Enanta Pharmaceuticals for the period between Thu, May 8, 2025 and Wed, Aug 6, 2025 has a statistical range of 3.05 with a coefficient of variation of 13.22. Under current investment horizon, the daily prices are spread out with arithmetic mean of 6.81. The median price for the last 90 days is 7.13.| Open | High | Low | Close | Volume | ||
08/06/2025 | 7.15 | 7.15 | 6.88 | 7.10 | ||
08/04/2025 | 7.15 | 7.15 | 6.88 | 7.10 | 103,300 | |
08/01/2025 | 7.42 | 7.65 | 7.10 | 7.11 | 195,593 | |
07/31/2025 | 7.56 | 7.58 | 7.37 | 7.58 | 183,125 | |
07/30/2025 | 8.18 | 8.31 | 7.56 | 7.61 | 276,292 | |
07/29/2025 | 8.01 | 8.15 | 7.86 | 8.10 | 123,692 | |
| 07/28/2025 | 7.78 | 8.17 | 7.50 | 8.03 | 292,702 | |
07/25/2025 | 7.38 | 7.45 | 7.15 | 7.40 | 65,773 | |
07/24/2025 | 7.72 | 7.75 | 7.33 | 7.34 | 93,488 | |
07/23/2025 | 7.77 | 7.89 | 7.49 | 7.73 | 167,702 | |
| 07/22/2025 | 7.72 | 7.89 | 7.49 | 7.67 | 269,589 | |
07/21/2025 | 7.56 | 8.11 | 7.24 | 7.73 | 362,369 | |
| 07/18/2025 | 7.33 | 7.90 | 7.27 | 7.54 | 213,585 | |
07/17/2025 | 7.12 | 7.42 | 7.10 | 7.23 | 113,866 | |
07/16/2025 | 6.59 | 7.11 | 6.44 | 7.09 | 215,697 | |
07/15/2025 | 6.97 | 7.00 | 6.47 | 6.59 | 259,534 | |
07/14/2025 | 6.57 | 6.97 | 6.53 | 6.96 | 111,434 | |
07/11/2025 | 6.92 | 7.04 | 6.50 | 6.56 | 189,480 | |
| 07/10/2025 | 7.14 | 7.14 | 6.88 | 6.98 | 148,399 | |
07/09/2025 | 7.86 | 7.90 | 7.06 | 7.13 | 255,062 | |
07/08/2025 | 7.65 | 7.93 | 7.56 | 7.75 | 114,671 | |
07/07/2025 | 7.88 | 8.00 | 7.57 | 7.65 | 94,106 | |
07/03/2025 | 8.03 | 8.03 | 7.73 | 7.89 | 78,004 | |
07/02/2025 | 7.73 | 8.23 | 7.71 | 7.97 | 209,818 | |
07/01/2025 | 7.52 | 7.83 | 7.51 | 7.70 | 135,156 | |
06/30/2025 | 7.49 | 7.62 | 7.37 | 7.56 | 156,827 | |
06/27/2025 | 7.55 | 7.72 | 7.34 | 7.50 | 234,296 | |
06/26/2025 | 7.51 | 7.53 | 7.23 | 7.51 | 79,092 | |
06/25/2025 | 7.34 | 7.47 | 7.00 | 7.45 | 173,629 | |
| 06/24/2025 | 7.21 | 7.42 | 7.00 | 7.32 | 143,709 | |
06/23/2025 | 7.10 | 7.25 | 6.95 | 7.12 | 84,153 | |
06/20/2025 | 7.36 | 7.41 | 6.96 | 7.18 | 183,679 | |
06/18/2025 | 7.04 | 7.34 | 6.87 | 7.23 | 99,048 | |
06/17/2025 | 7.24 | 7.44 | 7.03 | 7.05 | 123,925 | |
06/16/2025 | 7.54 | 7.54 | 7.17 | 7.28 | 120,413 | |
06/13/2025 | 7.21 | 7.87 | 7.16 | 7.50 | 243,942 | |
06/12/2025 | 7.88 | 8.03 | 7.34 | 7.41 | 278,227 | |
| 06/11/2025 | 7.65 | 8.47 | 7.48 | 7.95 | 674,229 | |
| 06/10/2025 | 7.49 | 7.70 | 7.01 | 7.58 | 254,834 | |
06/09/2025 | 7.56 | 7.56 | 7.26 | 7.50 | 134,499 | |
06/06/2025 | 7.31 | 7.65 | 7.30 | 7.47 | 118,894 | |
06/05/2025 | 7.11 | 7.21 | 6.94 | 7.21 | 99,322 | |
06/04/2025 | 7.11 | 7.41 | 7.08 | 7.11 | 141,124 | |
06/03/2025 | 6.44 | 7.25 | 6.38 | 7.19 | 345,065 | |
06/02/2025 | 5.99 | 6.36 | 5.88 | 6.29 | 121,725 | |
05/30/2025 | 6.12 | 6.18 | 5.89 | 5.93 | 176,864 | |
05/29/2025 | 5.88 | 6.23 | 5.87 | 6.16 | 91,483 | |
05/28/2025 | 5.83 | 5.94 | 5.78 | 5.87 | 44,879 | |
05/27/2025 | 5.83 | 5.94 | 5.70 | 5.82 | 100,731 | |
05/23/2025 | 5.64 | 5.92 | 5.55 | 5.81 | 67,700 | |
05/22/2025 | 5.72 | 5.92 | 5.64 | 5.75 | 44,298 | |
05/21/2025 | 5.98 | 6.05 | 5.68 | 5.79 | 156,188 | |
05/20/2025 | 5.97 | 6.10 | 5.84 | 6.07 | 148,323 | |
05/19/2025 | 5.64 | 5.97 | 5.63 | 5.96 | 131,354 | |
05/16/2025 | 5.40 | 5.86 | 5.39 | 5.75 | 99,711 | |
| 05/15/2025 | 5.18 | 5.38 | 5.04 | 5.37 | 81,390 | |
05/14/2025 | 5.21 | 5.35 | 5.03 | 5.18 | 116,227 | |
05/13/2025 | 5.51 | 5.60 | 5.20 | 5.23 | 170,994 | |
05/12/2025 | 5.43 | 5.71 | 5.28 | 5.55 | 106,054 | |
05/09/2025 | 5.31 | 5.52 | 5.25 | 5.27 | 81,513 | |
05/08/2025 | 5.08 | 5.34 | 4.96 | 5.32 | 128,703 |
About Enanta Pharmaceuticals Stock history
Enanta Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Enanta is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Enanta Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Enanta Pharmaceuticals stock prices may prove useful in developing a viable investing in Enanta Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 24.3 M | 19.6 M | |
| Net Loss | -109.6 M | -104.1 M |
Enanta Pharmaceuticals Quarterly Net Working Capital |
|
Enanta Pharmaceuticals Stock Technical Analysis
Enanta Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Sectors Now
SectorsList of equity sectors categorizing publicly traded companies based on their primary business activities |
| All Next | Launch Module |
Enanta Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Enanta Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Enanta Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Enanta to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0686 | |||
| Jensen Alpha | 0.3061 | |||
| Total Risk Alpha | (0.29) | |||
| Sortino Ratio | 0.0465 | |||
| Treynor Ratio | 6.36 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Enanta Stock analysis
When running Enanta Pharmaceuticals' price analysis, check to measure Enanta Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Enanta Pharmaceuticals is operating at the current time. Most of Enanta Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Enanta Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Enanta Pharmaceuticals' price. Additionally, you may evaluate how the addition of Enanta Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |